Thursday 22 October 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 485: (TSXV: $DB.V) (OTCQB: $DBCCF), (CSE: $XCX.C) (TSXV: $NUMI.V)
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 485: (TSXV: $DB.V) (OTCQB: $DBCCF), (CSE: $XCX.C) (TSXV: $NUMI.V)
Today's podcast sponsored by Cannabis Suisse Corp.
(OTC: $CSUI), a fully licensed cannabis cultivation and distribution company in
Switzerland
Delta, Kelowna, BC, October 22, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/102220-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/10221DB-DBCCF-XCX-NUMI.asp
Hear the investor ideas potcast on
Spotify
Hear Investor ideas cannabis potcast on iTunes
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s podcast is
sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis
cultivation and distribution company in Switzerland, for recreational tobacco
products and medical CBD oils. The Company's facilities for producing cannabis
are based in Dietikon, Switzerland, and contain the art surveillance equipment
to enable an around the clock webcast. Cannabis Suisse grows high quality,
organic cannabis with sustainable, all-natural principles. The Company's
products are laboratory tested to ensure the end users have access to a
standardized, safe and consistent product. Cannabis Suisse proprietary
trademarked MoldStandard is a quantitative microbiology method for analyzing
yeast and mold counts in harvested cannabis plants. Cannabis Suisse proprietary
trademarked CannaMec is a method for quantifying and removing residual solvents
during packaging and storage of CBD products. Cannabis Suisse Corp. currently
sells via a distribution network of Swiss retailers and online shops, under the
retail brand Alpine Cannabis.
In
today’s podcast we look at a few public and private company announcements.
Decibel
Cannabis Company Inc. (TSX-V:DB) (OTCQB:DBCCF), a premium cannabis producer and
retailer, announced the launch of cannabis derivative
products produced at its extraction facility, The Plant.
"Our product strategy is driven
by our intimate knowledge of the end consumer through our Prairie Records
retail stores," said Adam Coates, Chief Growth Officer of Decibel.
"This position allows for insights such as identifying whitespace
opportunities the current market is not fulfilling, and understanding key
product attributes consumers are looking for in established formats. With these
insights, we are launching black market quality concentrates, high potency,
strain specific vapes and the CÜE line of fast acting 10mg THC shot style
beverages."
Product
Launch Highlights
● 10 Product Skus Launched: Achieved
its first 57 product sku registrations in Western Canada and a supply agreement
with the Ontario Cannabis Retail Corporation, with 10 skus currently available
in cannabis retail stores across British Columbia, Alberta and Saskatchewan.
The first shipments of products were delivered in late Q3.
● Blendcraft by Qwest Concentrates: Decibel's
first derivative product launches under the Blendcraft by Qwest banner with 4
skus of Wax (crumble) and 4 skus of Shatter. These high potency, in demand
concentrates compliment the rare cultivar, craft dried flower products the
Company produces under the Qwest Family of Brands.
● General Admission Vapes: Decibel
has launched its new brand, General Admission, with four strain specific vapes
(Berry G 33, Tropic GSC, Lemon Ice and Tropic Thunder) in 0.45g and 0.95g
cartridges, and 0.3g disposable formats. With high potency THC dominant and
THC/CBD balanced formulations and a strong value-for-price ratio, first
shipments of these products have been successful with re-orders from initial
product shipments achieved within the first week of launch.
● CÜE Fast Acting Cannabis Shots: The
Company has entered into a definitive agreement with Origin Scientific Inc., a
private Canadian company, to manufacture and distribute CÜE fast acting
cannabis shots. CÜE has developed an industry leading, clinically proven and
patented nano encapsulation technology that has been formulated into a
fast-acting cannabis infused shot style beverage. "CÜE Lemon Tea", a
59ml cannabis shot with 10mg of THC and 30mg of naturally occurring caffeine is
expected to be the initial product offering, which the Company anticipates to
be available for sale in November.
AMP
German Cannabis Group Inc. (CSE: XCX) providing German patients with a
wide range of pharmaceutical grade medical cannabis products, announced it will be adding Little Green Pharma Ltd. (ASX: LGP) cannabis oil medicines to its
catalogue for sale in Germany beginning in November 2020 subject to obtaining a
BtM-registration (narcotic drug licence) of these products on behalf of AMP.
AMP is looking forward to offering
premium EU-GMP full plant extract cannabis oil medicines branded under the LGP
Classic brand, produced by the same consistent strains. AMP wants to introduce the LGP brand to the
German market by selling "LGP Classic 20:5 Oils" (THC dominant) and
additional products in the near term once AMP has established the brand in the
German market. Whereas LGP`s full plant extracts originate from the same
cannabis plants, many other cannabis extracts are sourced from varying cannabis
plants.
Little Green Pharma is licenced to
cultivate and produce medical cannabis in Australia and has obtained the
required licences and permits to export to Germany. Little Green Pharma has its
own Therapeutic Goods Administration ("TGA") GMP licensed
manufacturing facility in addition to a six-year, exclusive manufacturing
agreement with a third-party TGA-GMP licensed contract manufacturer based in Western
Australia. The TGA-GMP certification, granted by Australia's Department of
Health, is recognized by EU regulatory authorities as meeting EU-GMP standards
enabling LGP products to be sold in Germany.
Dr. Stefan Feuerstein, Director and
President of AMP, said: "We had a lot of requests for medical cannabis
oils during our recent sales trip through Germany, where we met with
medium-sized distributors and large pharmacists that are specializing in
medical cannabis. To meet this demand,
we are introducing the premium LGP Classic brand as our first extract brand for
the German market. We wanted our first extract in our product line to be a
premium, full plant extract that our sales team can introduce along with our
other medical cannabis flower products. We will be adding additional cannabis
oils in the coming months to satisfy our customers' strong demand for this
product line."
Ms. Fleta Solomon, Managing Director
of Little Green Pharma, commented,
"Our focus is on producing the highest quality cannabis medicines for
Australia and other countries where medicinal cannabis has been legalized. We
are proud to be the first Australian company to supply Germany, the leading
medicinal cannabis market in Europe, and that AMP will be introducing the LGP
Classic brand. We expect strong sales
from AMP as they immediately launch and invest in introducing our LGP Classic
20:5 oil to the German market and additional LGP Classic products in the near
term."
Numinus Wellness
Inc. (TSXV: NUMI), a company creating an ecosystem
of health solutions centred on developing and supporting the safe,
evidence-based, accessible use of psychedelic-assisted psychotherapies, announced that they have harvested the first
legal flush of Psilocybe mushrooms in
Canada by a public company under its Health Canada-issued Controlled Drugs and
Substances Dealer's Licence. This news coincides with other recent developments
by Numinus Bioscience, the Company's 7,000 square foot analytics and research
laboratory, which is focused on handling various psychedelic substances and
developing analytical methods and formulations for the evolving psychedelics
space.
"The
first harvest of legally grown Psilocybe
mushrooms is a significant milestone for the whole industry" said Michael
Tan, Chief Operating Officer. "Now, we can progress with research and
development of standardized cultivation, extraction, and testing methods and
exploring product formulations to support safe, evidence-based, accessible
psychedelic-assisted psychotherapy, as well as build a sequenced spore library."
Dennis
McKenna, renowned ethnopharmacologist, Co-founder of the Heffter Research
Institute, Founder of the McKenna Academy of Natural Philosophy, and member of
Numinus' General Advisory Council, adds, "While there is a place for
synthetic psilocybin in clinical practice, well-characterized and standardized
extracts of natural forms of psilocybin i.e., mushrooms, cultivated and
processed under stringent quality control protocols, are the wave of the future
as therapeutic psilocybin gains acceptance. Given a choice, many people would
prefer the option to use natural psilocybin. Mushrooms have been used in
traditional medicine for literally thousands of years, and hence, they are just
that much closer to these ancient traditions. Natural mushroom extracts are also
likely to be far more affordable compared to synthetic psilocybin, and that is
an important consideration when it comes to ensuring accessibility to this
medicine which can be so beneficial to many people. Cost should not be a
barrier to access these medicines, and the use of mushroom extracts will help
ensure those who need them most can benefit from psilocybin therapies."
Numinus
Bioscience is establishing itself at the forefront of analytical testing for
psychedelic substances, as a centre of excellence for psychedelic product
research and development, and as an ancillary for psychedelic therapy clinical
trials. Health Canada licences, scientific expertise, and state-of-the-art
technologies facilitate ongoing innovation, while revenue from high-throughput
contract cannabis testing is reinvested to further its psychedelic initiatives.
In
addition to today's announcement, Numinus includes in its recent developments
an amendment application to its Health Canada-issued Controlled Drugs and
Substances Licence. The current licence permits testing, import and export,
storage and distribution of MDMA, Psilocybin, Psilocin, DMT, and Mescaline as
well as the undertaking of novel mycological research initiatives. The
amendment will additionally permit the sale of Psilocybe mushroom fruiting bodies and extract for clinical
research protocols and the development of standardized testing for additional
psychedelic substances.
Numinus
is also proud to announce the recent appointment of Sharan Sidhu, regulatory expert
and policy advisor for restrictive high growth industries, as Science Officer
and General Manager. Sidhu brings extensive experience as a hub between
academia, industry, and governing directorates to align research objectives
with regulatory compliance. She has been a key strategist for research
roadmaps, core initiatives, the development of IP, and the development of
compliance requirements including LIMS, GLP/GMP, GACP, and ISO Standards.
"Sharan's
experience and leadership are already proving instrumental in establishing
Numinus Bioscience as a centre of excellence and major industry player in the
delivery of safe, evidence-based, accessible psychedelic-psychotherapy,"
said Payton Nyquvest, CEO, Founder, and Chairman. "We are honoured to have
her join us on our mission."
Once again, today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investors can trade these stocks
and other ideas on our site using our list of
top stock trading apps including
Robinhood, Acorn, Stash and others.
To hear more
Investorideas.com podcasts visit:
https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. Disclosure: Cannabis Suisse Corp. (OTC: CSUI),is a paid featured company on
Investorideas.com More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor
Ideas – news, articles, podcasts and stock
directory
Wednesday 21 October 2020
Tuesday 20 October 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 484 (CSE: $TGIF.C) (OTCQX: $TGIFF) (CSE: $ORCD.C) (OTC: $ORVRF) (OTC: $MJNA) (OTCQB: $ALID)
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 484 (CSE: $TGIF.C) (OTCQX: $TGIFF) (CSE: $ORCD.C) (OTC: $ORVRF) (OTC: $MJNA) (OTCQB: $ALID)
Today's
podcast sponsored by Cannabis Suisse Corp. (OTC: $CSUI), a fully licensed cannabis
cultivation and distribution company in Switzerland
Delta, Kelowna, BC, October 20, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/102020-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/10201TGIFF-ORCD-ORVRF-MJNA-ALID.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s podcast is
sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully
licensed cannabis cultivation and distribution company in Switzerland, for
recreational tobacco products and medical CBD oils. The Company's facilities
for producing cannabis are based in Dietikon, Switzerland, and contain the art
surveillance equipment to enable an around the clock webcast. Cannabis Suisse
grows high quality, organic cannabis with sustainable, all-natural principles.
The Company's products are laboratory tested to ensure the end users have
access to a standardized, safe and consistent product. Cannabis Suisse
proprietary trademarked MoldStandard is a quantitative microbiology method for
analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse
proprietary trademarked CannaMec is a method for quantifying and removing
residual solvents during packaging and storage of CBD products. Cannabis Suisse
Corp. currently sells via a distribution network of Swiss retailers and online shops,
under the retail brand Alpine Cannabis.
In
today’s podcast we look at a few public and private company announcements.
1933
Industries Inc. (CSE:
TGIF) (OTCQX:
TGIFF), together with Orchid
Ventures Inc. (CSE:
ORCD) (OTC:
ORVRF) announced that
they have entered into a Supply and Licensing Agreement for the manufacturing
and distribution of Orchid products into the regulated Nevada cannabis market.
Washington-based Orchid Ventures,
Inc., through its wholly owned subsidiary, Orchid Brands, LLC, has entered into
an exclusive agreement with 1933 Industries' subsidiary, Alternative Medicine
Association LLC ("AMA"), for the purposes of manufacturing, selling
and marketing Orchid Essentials Brand products in Nevada, leveraging AMA's
extraction expertise and well-established sales and distribution channels in
the state.
Pursuant to the terms of the
three-year Agreement, 1933 Industries will purchase Orchid's PurTec hardware
and packaging component products and proprietary terpene blends required for
the production of Orchid Essentials products.
AMA will act as the exclusive supplier of the Orchid Essentials Brand
Products and future lines, and will also purchase the same hardware components,
packaging and terpenes for its own branded products under the same pricing
terms. PurTec's Orchid cartridges are one of the only cartridges for cannabis
oil that are emissions tested at AFNOR standards, the strictest guidelines set
by the European Union. Orchid's unique cannabis products and proven
intellectual property will complement the Company's portfolio of trusted
brands.
"Bringing the Orchid Essentials
brand and PurTec hardware to Nevada as its exclusive carrier is a significant
strategic alliance for the Company", stated Mr. Eugene Ruiz, President of
1933 Industries. "This is a unique opportunity to partner with a company
that enables us to expand our offerings with complimentary products, enhance
our own delivery systems, improve our terpene profiles and support our
sustainability mandate. PurTec's eco-friendly, plastic free, wind energy
manufactured, child resistant retail packaging cartons and high emissions
standards provide sustainable product innovation that will differentiate our
products with increased consumer appeal. We are excited to launch new, advanced
and safe products in the vape segment, within our portfolio of premium products
and we look forward to representing the Orchid brand in Nevada."
"We are pleased to announce
another licensing partner for our Orchid brand as we expand the franchise into
the state of Nevada. Given our strong brand presence in Southern California,
we've sold products to many consumers traveling from Nevada, and have
previously met with buyers from marquee dispensaries in Vegas, with great
reception", said Mr. Rick Brown, President of Orchid Ventures. "We
feel that Orchid is highly differentiated from the existing vape products
available in Nevada and that the traveling consumer in this market will help
further spread brand awareness of Orchid Essentials. 1933 Industries has been a
market leader in Nevada for many years and they have built an extensive retail
distribution network through their strong marketing and sales capability. Their
focus on quality and innovation coupled with their proven track record as a
licensee of other brands, makes 1933 Industries the perfect partner for Orchid
in Nevada, as we continue to expand the brand nation-wide".
The launch program will focus on the
Orchid Classic 0.5 gram high quality vape product line, with associated
packaging consistent with all Nevada Cannabis Compliance Board (CCB) rules and
regulations, an optimal selection of terpene profiles and the Orchid 650 mAh
batteries, also with associated CCB compliant packaging. Orchid's extensive
all-natural terpene line meets a minimum of 97% purity, are third-party tested
and are ISO certified. The products will be available in select dispensaries by
December 2020.
Canadian cannabis skincare line, Empyri announced their
company launch today.
Company founder, Jennifer Grant is a
biochemical engineer by trade and brings her science-based formulas to life
through the empyri skincare line. Jennifer's goal is to promote invigorated wellness
and a sustainable lifestyle that helps connect people to their personal health
and the world around them.
The launch of empyri has been
several years in the making. From years of testing in her laboratory to
perfecting the efficacy of each formulation, the launch of empyri has been a
journey of passion and perseverance. This health-focused mother of three is
truly excited to introduce the benefits of empyri's cannabis root infused
products.
Clean and green is the heart of the
brand. What separates empyri skincare products from others is that empyri is
made from extracts of the cannabis root — an underused, yet potent part of the
cannabis plant. The cannabis root is at the foundation of each empyri product,
having been used in Traditional Chinese Medicine (TCM) for over a thousand
years.
"When approaching the creation
of this skincare line, my vision and goal was to use real science and
engineering to create innovative products that nourish and heal," says
empyri founder, Jennifer Grant. "I'm thrilled to bring a line of products
to market that are not only infused with active cannabis root but are also
plant-powered and cruelty-free. Respecting well-being extends to the planet as
well at empyri — our products are sustainable and chemical-free, which is very
important to me."
Today, empyri launches online with
three products; cannabis sativa oil cleanser, cannabis sativa hydrating toner +
vitamin C and cannabis sativa daily moisturizer. These products are also
available together in the empyri 3-step ritual skincare system. All empryi
products are produced in a GMP facility, containing Canadian-grown cannabis
root. All products from empyri contain no THC or CBD; therefore, containing all
the healing qualities of the cannabis plant, without the psychoactive effects.
Currently for sale online, all
products from empyri can now be purchased at empyri.com. The team at empryi
have also begun testing a men's line along with a line of cannabis root infused
teas. These products are expected to launch in 2021.
Medical Marijuana, Inc. (OTC:
MJNA) announced
today that its subsidiary Kannaway® has launched a new
product line designed to support its Evolve eight-week health and fitness
program as well as other healthy lifestyles.
Led by
fitness and nutrition expert Dan Miller, Kannaway®’s Evolve is a complete
fitness and nutrition program that focuses on the fundamentals of evolutionary
science to help participants achieve their fitness goals. In addition to the
Evolve product line, participants who join the program receive an educational
booklet and tracking sheet, weekly live video training from Miller, and access
to a support community of over 1,500 fellow participants.
“Now
more than ever, we must get creative and find new ways to take extra care of
our health,” said Dan Miller, Kannaway® spokesperson. “These products are great
tools for those looking to become stronger, do more and feel their best every
day.”
The
three new botanical nutrition products are designed to support people on their
journey to a more fulfilling life by focusing on energy, movement, digestion,
and immune support. They include:
● Kannaway®
Core Hemp Protein Blend: Offered in both Chocolate Mousse and Vanilla Creme
Brulee flavors, this plant-based luxury hemp protein powder offers 15g of hemp
protein isolate per serving, finely ground whole hemp hearts and prebiotic
fiber. Mix each sachet with 6-12 ounces of water or plant-based milk.
●
Kannaway® Boost Immune Support Supplement:
Designed to utilize the synergy of Proimmune®’s Immune Formulation 200® and
Vitamin D, these support tablets strengthen your body’s natural immunity so you
can fight off immuno-compromising invaders and stress. Take two tablets each
day.
● Kannaway®
Spark Energy and Metabolism Booster: Crafted with guarana, taurine, bitter
orange root, cordyceps mushroom, and ashwagandha, these capsules naturally
support cellular energy and optimize the body's own metabolism. Take two
capsules midday to give you that extra push to finish the day strong.
“According
to GrandView Research analysts, the U.S. dietary supplement market is expected
to reach $230.73 billion by 2027,” said Kannaway CEO Blake Schroeder. “We are
proud to be able to offer our customers the high-quality products they desire
while continuing to focus our sales efforts on lucrative industries outside of
our core product category of hemp-based cannabidiol (CBD).”
Allied
Corp. (OTCQB:
ALID), an international medical cannabis company focused on
creating and providing targeted cannabinoid health solutions to address today’s
medical issues announced the
filing of a new United States provisional patent application entitled
“PSILOCYBIN COMPOSITIONS AND FORMULATIONS AND THEIR USE IN TREATING MENTAL HEALTH
DISORDERS AND IMPROVING MENTAL HEALTH”. The provisional patent application
covers a novel combination of psilocybin and proprietary mushroom formulation,
as well as a novel treatment regimen targeting Post Traumatic Stress (PTSD),
Depression and General Anxiety.
Psilocybin is the active
pharmaceutical ingredient contained in the Golden Teacher psychedelic mushroom.
Along with the novel treatment regimen, Allied’s formulation consists of novel
micro-dose ratios of several medical mushroom compounds combined with
additional natural health molecules.
“Adding the psilocybin
pharmaceutical product leverages our clinical trial expertise and
infrastructure while simultaneously broadening our product offering beyond
cannabis,” said Calum Hughes, CEO of Allied. “With this provisional patent
application, we have deepened our pharmaceutical pipeline in our key
therapeutic areas of PTSD, Depression and General Anxiety.”
Once again, today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investors can trade these stocks
and other ideas on our site using our list of top stock trading
apps including Robinhood, Acorn,
Stash and others.
To hear more Investorideas.com
podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast and column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Disclosure: Cannabis
Suisse Corp. (OTC: CSUI),is
a paid featured company on Investorideas.com Contact
management and IR of each company directly regarding specific questions. More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news,
articles, podcasts and
stock directory
Subscribe to:
Posts (Atom)
-
Investorideas.com - Cannabis Stock News: TransCanna (CSE: TCAN) Product Ranks in Leafly's Top Cannabis Strains List
-
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ...